Using mitochondrial sirtuins as drug targets: disease implications and available compounds.
about
SIRT3 in Cardiac Physiology and DiseaseStructural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.Segmental Aging Underlies the Development of a Parkinson Phenotype in the AS/AGU Rat.Chronic Ethanol Metabolism Inhibits Hepatic Mitochondrial Superoxide Dismutase via Lysine Acetylation.The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning.During yeast chronological aging resveratrol supplementation results in a short-lived phenotype Sir2-dependent.Mitochondrial sirtuins in the heart.Could Sirtuin Activities Modify ALS Onset and Progression?Crystal structures of the mitochondrial deacylase Sirtuin 4 reveal isoform-specific acyl recognition and regulation features.Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight.SIRT3: A New Regulator of Cardiovascular Diseases.Structural Basis of Sirtuin 6 Activation by Synthetic Small MoleculesIdentification of the missing mitochondrial methyltransferase of citrate synthase
P2860
Q28076837-AA225D34-F936-4E9C-9852-5EC605BB0F62Q30313597-28D72192-D46A-4676-A5E8-11305855306EQ37533588-7DADE94E-F19E-4148-8822-70CD0113EB9DQ38626482-14F0FE2C-3DFD-4BDA-9F57-7D7FF028888CQ38661899-1C13744B-6E57-4442-8B14-7C1435516749Q38835403-7E859F70-E678-4792-99C1-1B1CBABEDF11Q38863483-1F3B454A-1FDE-4779-86A0-13A4E44E0901Q39036105-0DF4A8CC-E863-4EEB-AE2E-C70DE4590385Q47171465-BB84D771-4CC7-48FE-8A7B-3A56B50E5362Q47890805-139F0EDC-0308-43B1-A62C-4ED6924AE3DDQ52592887-8584329A-62D6-4E84-A6DB-2366E738BD87Q56925925-F7389A19-6897-4C62-ADDE-D8B58F74FEA7Q58036600-967BBF1D-5D11-4147-A391-D5E2737DEAE4
P2860
Using mitochondrial sirtuins as drug targets: disease implications and available compounds.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Using mitochondrial sirtuins a ...... tions and available compounds.
@ast
Using mitochondrial sirtuins a ...... tions and available compounds.
@en
type
label
Using mitochondrial sirtuins a ...... tions and available compounds.
@ast
Using mitochondrial sirtuins a ...... tions and available compounds.
@en
prefLabel
Using mitochondrial sirtuins a ...... tions and available compounds.
@ast
Using mitochondrial sirtuins a ...... tions and available compounds.
@en
P2860
P1476
Using mitochondrial sirtuins a ...... tions and available compounds.
@en
P2093
Clemens Steegborn
Melanie Gertz
P2860
P2888
P304
P356
10.1007/S00018-016-2180-7
P577
2016-03-23T00:00:00Z